Clinical Characteristics and Primary Outcomes of Patients with ANCA-associated Vasculitis and Central Diabetes Insipidus

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2023 May 30

PMID 37251686

Authors

Xin Chen

Shuo Zhang

Xia Peng

Xiaoxiao Shi

Haiting Wu

YuBing Wen

Yan Qin

Xinping Tian

Huijuan Zhu

Limeng Chen

Affiliations

Soon will be listed here.

Abstract

Introduction: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is characterized by systemic small-vessel vasculitis and may rarely present as central diabetes insipidus (CDI). In this study, we aimed to determine the clinical characteristics and prognosis of patients with AAV-associated CDI.

Methods: This was a nested case-control study where AAV patients with CDI at the Peking Union Medical College Hospital were followed from January 2012 to April 2022. Case-control matching with AAV patients without CDI was performed (1:5), and participants were matched by age, sex, and AAV classification. We collected clinical data every 3-6 months and conducted a literature review using PubMed to identify relevant articles published from 1983-2022.

Results: Among 1203 hospitalized AAV patients, 16 patients with CDI were included (1.3%). The average age was 49 years, and men accounted for 56.3%. Granulomatosis with polyangiitis (GPA) accounted for 87.5% of patients. AAV patients with CDI had more ear, nose, and throat (ENT) (81.3%) involvement and less renal impairment than those in the control group (P<0.05). After a mean follow-up of four years, 50% of patients were in remission from AAV, 37.5% relapsed, and 12.5% died. Our literature review suggested that patients in Asian countries tend to be older men and have higher myeloperoxidase (MPO-ANCA) positivity than those in Western countries. Furthermore, proteinase 3 (PR3-ANCA) positivity may predict disease recurrence.

Discussion: AAV patients with CDI had more ENT involvement and a higher eGFR. MPO-ANCA positivity is more commonly observed in Asian countries than Western countries, and PR3-ANCA positivity may predict recurrence.

References

Thiryayi W, Donaldson M, Border D, Tyagi A . An enhancing pituitary lesion in a young woman: a diagnostic dilemma. J Clin Neurosci. 2006; 14(3):286-8. DOI: 10.1016/j.jocn.2005.12.005. View

de Parisot A, Puechal X, Langrand C, Raverot G, Gil H, Perard L . Pituitary involvement in granulomatosis with polyangiitis: report of 9 patients and review of the literature. Medicine (Baltimore). 2015; 94(16):e748. PMC: 4602700. DOI: 10.1097/MD.0000000000000748. View

Li C, Zou Y, Lu X, Wang G, Shu X . Pituitary dysfunction in patients with ANCA associated vasculitis: prevalence, presentation, and outcomes. Ther Adv Chronic Dis. 2020; 11:2040622320930636. PMC: 7285954. DOI: 10.1177/2040622320930636. View

Kitching A, Anders H, Basu N, Brouwer E, Gordon J, Jayne D . ANCA-associated vasculitis. Nat Rev Dis Primers. 2020; 6(1):71. DOI: 10.1038/s41572-020-0204-y. View

Tao J, Dong Y . Pituitary involvement in Wegener's granulomatosis: a case report and review of the literature. Chin Med J (Engl). 2003; 116(11):1785-8. View

Yasuda K, Sainouchi M, Goto M, Murase N, Ohtani R, Nakamura M . A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated hypertrophic pachymeningitis presenting with multiple cranial nerve palsies and diabetes insipidus. Rinsho Shinkeigaku. 2016; 56(5):334-7. DOI: 10.5692/clinicalneurol.cn-000859. View

Fussner L, Hummel A, Schroeder D, Silva F, Cartin-Ceba R, Snyder M . Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3. Arthritis Rheumatol. 2016; 68(7):1700-10. PMC: 7137903. DOI: 10.1002/art.39637. View

Kapoor E, Cartin-Ceba R, Specks U, Leavitt J, Erickson B, Erickson D . Pituitary dysfunction in granulomatosis with polyangiitis: the Mayo Clinic experience. J Clin Endocrinol Metab. 2014; 99(11):3988-94. DOI: 10.1210/jc.2014-1962. View

Asakura K, Ogata H, Omatsu M, Yamamoto M, Yoshida K, Ito H . A case of nephrogenic diabetes insipidus likely caused by anti-neutrophil cytoplastic antibody-associated vasculitis. CEN Case Rep. 2022; 12(2):189-194. PMC: 10151446. DOI: 10.1007/s13730-022-00741-y. View

10.

Garrahy A, Moran C, Thompson C . Diagnosis and management of central diabetes insipidus in adults. Clin Endocrinol (Oxf). 2018; 90(1):23-30. DOI: 10.1111/cen.13866. View

11.

Yong T, Li J, Amato L, Mahadevan K, Phillips P, Coates P . Pituitary involvement in Wegener's granulomatosis. Pituitary. 2007; 11(1):77-84. DOI: 10.1007/s11102-007-0021-2. View

12.

Takuma H, Shimada H, Inoue Y, Ishimura E, Himuro K, Miki T . Hypertrophic pachymeningitis with anti-neutrophil cytoplasmic antibody (p-ANCA), and diabetes insipidus. Acta Neurol Scand. 2002; 104(6):397-401. DOI: 10.1034/j.1600-0404.2001.00056.x. View

13.

Spisek R, Kolouchova E, Jensovsky J, Rusina R, Fendrych P, Plas J . Combined CNS and pituitary involvement as a primary manifestation of Wegener granulomatosis. Clin Rheumatol. 2005; 25(5):739-42. DOI: 10.1007/s10067-005-0065-5. View

14.

Lyons P, Rayner T, Trivedi S, Holle J, Watts R, Jayne D . Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med. 2012; 367(3):214-23. PMC: 3773907. DOI: 10.1056/NEJMoa1108735. View

15.

Xue J, Wang H, Wu H, Jin Q . Wegener's granulomatosis complicated by central diabetes insipidus and peripheral neutrophy with normal pituitary in a patient. Rheumatol Int. 2009; 29(10):1213-7. DOI: 10.1007/s00296-008-0774-6. View

16.

Goyal M, Kucharczyk W, Keystone E . Granulomatous hypophysitis due to Wegener's granulomatosis. AJNR Am J Neuroradiol. 2000; 21(8):1466-9. PMC: 7974053. View

17.

Hilhorst M, van Paassen P, Cohen Tervaert J . Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis. J Am Soc Nephrol. 2015; 26(10):2314-27. PMC: 4587702. DOI: 10.1681/ASN.2014090903. View

18.

Kara O, Demirel F, Celikel Acar B, Cakar N . Wegener granulomatosis as an uncommon cause of panhypopituitarism in childhood. J Pediatr Endocrinol Metab. 2013; 26(9-10):959-62. DOI: 10.1515/jpem-2013-0033. View

19.

Duzgun N, Morris Y, Gullu S, Gursoy A, Ensari A, Ozdemir Kumbasar O . Diabetes insipidus presentation before renal and pulmonary features in a patient with Wegener's granulomatosis. Rheumatol Int. 2005; 26(1):80-2. DOI: 10.1007/s00296-005-0583-0. View

20.

Al-Fakhouri A, Manadan A, Gan J, Sreih A . Central diabetes insipidus as the presenting symptom of granulomatosis with polyangiitis. J Clin Rheumatol. 2014; 20(3):151-4. DOI: 10.1097/RHU.0000000000000093. View